FDA Approved: CREXONT — Original Application (Amneal Pharmaceuticals LLC)

View source ↗

Summary

The FDA approved CREXONT, a carbidopa-levodopa product from Amneal Pharmaceuticals, under an Original Application (NDA217186).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• CREXONT (carbidopa and levodopa)

Snippet

ORIG AP for CREXONT (CARBIDOPA AND LEVODOPA)